Understanding objective performance goals for critical limb ischemia trials

Seminars in Vascular Surgery

Volumn 23, Issue 3, 2010, Pages 129-137

  Conte, Michael S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CRITICAL ILLNESS; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HIGH RISK PATIENT; HUMAN; LEG REVASCULARIZATION; LIMB ISCHEMIA; LIMB MOVEMENT; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STUDY DESIGN; SURVIVAL RATE;

AMPUTATION; BENCHMARKING; CLINICAL TRIALS AS TOPIC; CRITICAL ILLNESS; DISEASE-FREE SURVIVAL; ENDPOINT DETERMINATION; EVIDENCE-BASED MEDICINE; EXTREMITIES; HUMANS; ISCHEMIA; LIMB SALVAGE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; QUALITY INDICATORS, HEALTH CARE; REOPERATION; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 77956327633     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2010.06.001     Document Type: Article

References (21)

1. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007, 45(suppl S):S5-S67.
2. Adam D.J., Beard J.D., Cleveland T., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005, 366:1925-1934. 9501.
3. Bradbury A.W., Adam D.J., Bell J., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010, 51(suppl):5S-17S.
4. Bradbury A.W., Adam D.J., Bell J., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg 2010, 51(suppl):18S-31S.
5. Conte M.S. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia. J Vasc Surg 2010, 51(suppl):69S-75S.
6. Chen E., Sapirstein W., Ahn C., Swain J., Zuckerman B. FDA perspective on clinical trial design for cardiovascular devices. Ann Thorac Surg 2006, 82:773-775.
7. Grunkemeier G.L., Jin R., Starr A. Prosthetic heart valves: objective performance criteria versus randomized clinical trial. Ann Thorac Surg 2006, 82:776-780.
8. Rocha-Singh K.J., Jaff M.R., Crabtree T.R., Bloch D.A., Ansel G. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv 2007, 69:910-919.
9. Conte M.S., Geraghty P.J., Bradbury A.W., et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 2009, 50:1462-1473.
10. Geraghty P.J., Matsumura J.S., Conte M.S. Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals. J Vasc Surg 2009, 50:1459-1461.
11. Conte M.S., Bandyk D.F., Clowes A.W., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006, 43:742-751. discussion 751.
12. Brass E.P., Anthony R., Dormandy J., et al. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg 2006, 43:752-759.
13. Nehler M.R., Brass E.P., Anthony R., et al. Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes. J Vasc Surg 2007, 45:953-960. discussion 960-951.
14. Adam D.J., Beard J.D., Cleveland T., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005, 366:1925-1934. 9501.
15. Powell R.J., Simons M., Mendelsohn F.O., et al. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation 2008, 118:58-65.
16. Schanzer A., Hevelone N., Owens C.D., et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg 2007, 46:1180-1190. discussion 1190.
17. Rutherford R.B., Baker J.D., Ernst C., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997, 26:517-538.
18. Diehm N., Baumgartner I., Jaff M., et al. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J 2007, 28:798-805.
19. Goodney PP, Schanzer A, DeMartino R, et al: Do objective performance goals (OPGs) for critical limb ischemia (CLI) apply to everyday vascular surgery practice? Paper presented at Society for Vascular Surgery Vascular Annual Meeting, Boston, MA, 2010.
20. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006, 113:e463-e654.
21. Conte M.S., Bandyk D.F., Clowes A.W., Moneta G.L., Namini H., Seely L. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg 2005, 42:456-464. discussion 464-455.